| 000 | 01500 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513075347.0 | ||
| 264 | 0 | _c19931103 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/endo.133.4.8404615 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchuster, W A | |
| 245 | 0 | 0 |
_aRetinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. _h[electronic resource] |
| 260 |
_bEndocrinology _cOct 1993 |
||
| 300 |
_a1724-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aEnzyme Induction |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xmetabolism |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 2 _xgenetics |
| 650 | 0 | 4 |
_aPlasminogen Activators _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
| 650 | 0 | 4 | _aTemplates, Genetic |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aTretinoin _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xgenetics |
| 700 | 1 | _aMedcalf, R L | |
| 700 | 1 | _aKruithof, E K | |
| 773 | 0 |
_tEndocrinology _gvol. 133 _gno. 4 _gp. 1724-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.133.4.8404615 _zAvailable from publisher's website |
| 999 |
_c8403888 _d8403888 |
||